应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
MENS 健永生技
交易中 12-15 10:59:03 EST
24.86
+0.05
+0.20%
最高
26.20
最低
23.63
成交量
1.56万
今开
23.63
昨收
24.81
日振幅
10.36%
总市值
18.90亿
流通市值
7.14亿
总股本
7,603万
成交额
38.71万
换手率
0.05%
流通股本
2,874万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
健永生技扩展区域合作，与越南制药分销商签署MOU，进入MCS-2市场
美股速递 · 12-04
健永生技扩展区域合作，与越南制药分销商签署MOU，进入MCS-2市场
健永生技有限公司与韩国领先制药公司签署非约束性意向书，评估植物来源Mcs药物的引进许可
美股速递 · 11-24
健永生技有限公司与韩国领先制药公司签署非约束性意向书，评估植物来源Mcs药物的引进许可
健永生技：Mcs-8仍为临床试验新药候选品，尚未在任何司法管辖区获得商业使用批准
美股速递 · 11-20
健永生技：Mcs-8仍为临床试验新药候选品，尚未在任何司法管辖区获得商业使用批准
健永生技宣布完成MCS-8二期临床试验主要终点统计分析，并取得积极成果
美股速递 · 11-20
健永生技宣布完成MCS-8二期临床试验主要终点统计分析，并取得积极成果
Jyong Biotech Ltd.盘中异动 股价大涨5.39%报40.25美元
市场透视 · 11-17
Jyong Biotech Ltd.盘中异动 股价大涨5.39%报40.25美元
Jyong Biotech Ltd.盘中异动 早盘大幅下跌5.01%报36.80美元
市场透视 · 11-12
Jyong Biotech Ltd.盘中异动 早盘大幅下跌5.01%报36.80美元
健永生技宣布MCS-8前列腺癌预防药物II期临床试验完成超700名受试者招募
美股速递 · 09-16
健永生技宣布MCS-8前列腺癌预防药物II期临床试验完成超700名受试者招募
暂无数据
公司概况
公司名称：
健永生技
所属市场：
NASDAQ
上市日期：
--
主营业务：
Jyong Biotech Ltd.是一家于2018年1月26日注册成立的开曼群岛豁免公司，主要通过在中国台湾的全资子公司开展业务。健永生技于2002年7月通过Health Ever Bio-Tech Co., Ltd.开始商业运营，该公司自2018年8月以来一直由Jyong Biotech Ltd.全资拥有。健永生技是一家科学驱动型生物技术公司，总部位于中国台湾，致力于开发和商业化创新和差异化新药（植物衍生），主要专注于泌尿系统疾病的治疗，最初的重点是美国、欧盟和亚洲市场。
发行价格：
--
{"stockData":{"symbol":"MENS","market":"US","secType":"STK","nameCN":"健永生技","latestPrice":24.86,"timestamp":1765814256068,"preClose":24.81,"halted":0,"volume":15628,"delay":0,"floatShares":28737800,"shares":76027667,"eps":-0.042184,"marketStatus":"交易中","change":0.05,"latestTime":"12-15 10:59:03 EST","open":23.63,"high":26.2,"low":23.63,"amount":387072.03794,"amplitude":0.103587,"askPrice":25.61,"askSize":200,"bidPrice":25,"bidSize":4,"shortable":0,"etf":0,"ttmEps":-0.042184,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"listingDate":1744862400000,"exchange":"NASDAQ","adjPreClose":24.81,"postHourTrading":{"tag":"盘后","latestPrice":25.17,"preClose":24.81,"latestTime":"16:10 EST","volume":2634,"amount":65529.59,"timestamp":1765573804047},"volumeRatio":0.686438},"requestUrl":"/m/hq/s/MENS/tweets","defaultTab":"tweets","newsList":[{"id":"1193390170","title":"健永生技扩展区域合作，与越南制药分销商签署MOU，进入MCS-2市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1193390170","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193390170?lang=zh_cn&edition=full","pubTime":"2025-12-04 21:31","pubTimestamp":1764855070,"startTime":"0","endTime":"0","summary":"健永生技扩展区域合作，与越南制药分销商签署MOU，进入MCS-2市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"1174979431","title":"健永生技有限公司与韩国领先制药公司签署非约束性意向书，评估植物来源Mcs药物的引进许可","url":"https://stock-news.laohu8.com/highlight/detail?id=1174979431","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174979431?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:34","pubTimestamp":1763991278,"startTime":"0","endTime":"0","summary":"健永生技有限公司与韩国领先制药公司签署非约束性意向书，评估植物来源Mcs药物的引进许可","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"1181632438","title":"健永生技：Mcs-8仍为临床试验新药候选品，尚未在任何司法管辖区获得商业使用批准","url":"https://stock-news.laohu8.com/highlight/detail?id=1181632438","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181632438?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:32","pubTimestamp":1763645550,"startTime":"0","endTime":"0","summary":"健永生技：Mcs-8仍为临床试验新药候选品，尚未在任何司法管辖区获得商业使用批准","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MENS","BK4139"],"gpt_icon":0},{"id":"1121886024","title":"健永生技宣布完成MCS-8二期临床试验主要终点统计分析，并取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=1121886024","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121886024?lang=zh_cn&edition=full","pubTime":"2025-11-20 21:31","pubTimestamp":1763645502,"startTime":"0","endTime":"0","summary":"健永生技宣布完成MCS-8二期临床试验主要终点的统计分析，并取得了积极成果。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0},{"id":"2584672995","title":"Jyong Biotech Ltd.盘中异动 股价大涨5.39%报40.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584672995","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584672995?lang=zh_cn&edition=full","pubTime":"2025-11-17 22:31","pubTimestamp":1763389868,"startTime":"0","endTime":"0","summary":"北京时间2025年11月17日22时31分，Jyong Biotech Ltd.股票出现波动，股价快速上涨5.39%。截至发稿，该股报40.25美元/股，成交量759股，换手率0.00%，振幅0.00%。Jyong Biotech Ltd.股票所在的生物技术行业中，整体涨幅为0.38%。Jyong Biotech Ltd.公司简介：Jyong Biotech Ltd是一家以科学为导向的台湾生物技术公司，致力于开发和商业化以泌尿系统疾病治疗为主的创新和差异化新药，最初的市场重点是美国，欧盟和亚洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223108a6ff9f88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251117223108a6ff9f88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MENS","JYB"],"gpt_icon":0},{"id":"2582537515","title":"Jyong Biotech Ltd.盘中异动 早盘大幅下跌5.01%报36.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582537515","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582537515?lang=zh_cn&edition=full","pubTime":"2025-11-12 00:29","pubTimestamp":1762878574,"startTime":"0","endTime":"0","summary":"北京时间2025年11月12日00时29分，Jyong Biotech Ltd.股票出现异动，股价快速下跌5.01%。截至发稿，该股报36.80美元/股，成交量21.4786万股，换手率0.28%，振幅5.89%。Jyong Biotech Ltd.股票所在的生物技术行业中，整体涨幅为1.26%。Jyong Biotech Ltd.公司简介：Jyong Biotech Ltd是一家以科学为导向的台湾生物技术公司，致力于开发和商业化以泌尿系统疾病治疗为主的创新和差异化新药，最初的市场重点是美国，欧盟和亚洲。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112002934a6f26860&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251112002934a6f26860&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["JYB","BK4139","MENS"],"gpt_icon":0},{"id":"1126531796","title":"健永生技宣布MCS-8前列腺癌预防药物II期临床试验完成超700名受试者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1126531796","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126531796?lang=zh_cn&edition=full","pubTime":"2025-09-16 20:19","pubTimestamp":1758025157,"startTime":"0","endTime":"0","summary":"健永生技宣布MCS-8前列腺癌预防药物II期临床试验完成超700名受试者招募","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","MENS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.healtheverbiotech.com","stockEarnings":[{"period":"1week","weight":-0.1503},{"period":"1month","weight":-0.324},{"period":"3month","weight":-0.5966},{"period":"6month","weight":2.308},{"period":"1year","weight":2.308},{"period":"ytd","weight":2.308}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Jyong Biotech Ltd.是一家于2018年1月26日注册成立的开曼群岛豁免公司，主要通过在中国台湾的全资子公司开展业务。健永生技于2002年7月通过Health Ever Bio-Tech Co., Ltd.开始商业运营，该公司自2018年8月以来一直由Jyong Biotech Ltd.全资拥有。健永生技是一家科学驱动型生物技术公司，总部位于中国台湾，致力于开发和商业化创新和差异化新药（植物衍生），主要专注于泌尿系统疾病的治疗，最初的重点是美国、欧盟和亚洲市场。","exchange":"NASDAQ","name":"健永生技","nameEN":"Jyong Biotech"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"健永生技(MENS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供健永生技(MENS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"健永生技,MENS,健永生技股票,健永生技股票老虎,健永生技股票老虎国际,健永生技行情,健永生技股票行情,健永生技股价,健永生技股市,健永生技股票价格,健永生技股票交易,健永生技股票购买,健永生技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"健永生技(MENS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供健永生技(MENS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}